Nexgel (NXGLW) Gross Profit Growth (3y) (2021 - 2025)
Nexgel (NXGLW) Gross Profit Growth (3y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 18.71% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 3.30% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 7.11% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 11.73% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 4.15% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 2.65% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 8.05% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 0.06% |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | 85.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 183.35% |
| Sep 30, 2025 | 103.27% |
| Jun 30, 2025 | 131.80% |
| Mar 31, 2025 | 282.59% |
| Dec 31, 2024 | 118.47% |
| Sep 30, 2024 | 181.32% |
| Jun 30, 2024 | 318.41% |
| Mar 31, 2024 | 79.77% |
| Dec 31, 2023 | 14.25% |
| Sep 30, 2023 | 145.19% |
| Jun 30, 2023 | 59.51% |
| Mar 31, 2023 | -41.79% |
| Dec 31, 2022 | 43.79% |
| Sep 30, 2022 | 25.99% |
| Mar 31, 2022 | 41.16% |
| Dec 31, 2021 | 4.60% |
| Sep 30, 2021 | -78.63% |